New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
09:06 EDTDYAXDyax 8M share Spot Secondary priced at $9.25
The deal priced in the middle of the $9.00-$9.50. Jefferies acted as lead book running manager for the offering.
News For DYAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 29, 2015
16:09 EDTDYAXDyax backs FY15 view of KALBITOR net sales $60M-$70M
Dyax has re-iterated its financial guidance for 2015. Revenue guidance includes two components: KALBITOR net sales in the range of $60M-$70M, reflecting the company's expectation that quarterly and annual KALBITOR net sales will fluctuate due to continued volatility in the level of KALBITOR utilization for individual patients. This volatility in utilization rates is due to fluctuations in the number of HAE attacks experienced by patients and the consistency with which patients treat their HAE attacks with KALBITOR; Development and license fees in the range of $7M-$9M. These fees exclude all potential royalties which would be earned from licensees' sales of LFRP product.
16:08 EDTDYAXDyax reports Q1 EPS (5c), consensus (5c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use